Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With CirrhosisCLINICAL AND TRANSLATIONAL GASTROENTEROLOGYIF32015-07-01277OAAI
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosisJOURNAL OF CACHEXIA SARCOPENIA AND MUSCLEIF9.12015-06-09386OAAI
Associations Between Objectively Measured Physical Activity and Quality of Life in Cancer Patients With Brain MetastasesJOURNAL OF PAIN AND SYMPTOM MANAGEMENTIF3.52014-09-0128OAAI
Correlates of objectively measured sedentary behavior in cancer patients with brain metastases: an application of the theory of planned behaviorPSYCHO-ONCOLOGYIF3.52014-07-2914PREAI
Severe Muscle Depletion Predicts Postoperative Length of Stay but Is Not Associated With Survival After Liver TransplantationLIVER TRANSPLANTATIONIF3.92014-06-01258PREAI
Sarcopenic Obesity and Muscle Fat Infiltration Are Associated with Higher Mortality in Patients with CirrhosisAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62013-10-010PREAI
NEW CUTOFF VALUES FOR SARCOPENIA FOR PREDICTING 6-MONTH MORTALITY IN CIRRHOTIC PATIENTSJOURNAL OF HEPATOLOGYIF332013-04-0116PREAI
Palliative Care Providers' Opinions of the Edmonton Symptom Assessment System Revised (ESAS-r) in Clinical PracticeJOURNAL OF PAIN AND SYMPTOM MANAGEMENTIF3.52012-11-017OAAI
Muscle Wasting Is Not Associated With Higher Mortality Aft er Liver TransplantationAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62012-10-012PREAI
The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinementPSYCHO-ONCOLOGYIF3.52011-06-13175PREAI
A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care PatientsJOURNAL OF PAIN AND SYMPTOM MANAGEMENTIF3.52011-02-01286OAAI
The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991-2006)PALLIATIVE MEDICINEIF3.92008-03-01230PREAI